Myrbetriq
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0469-2602 -
Package NDC
0469-2602-07 -
Package NDC
0469-2602-30 -
Package NDC
0469-2602-90 -
Application number
NDA202611 -
SPL ID
fe8998d8-cf08-4e07-b966-33e8de20abf1 -
SPL set ID
ba9e9e15-e666-4c56-9271-2e24739cfa2d -
UNII
MVR3JL3B2V -
RxCUI
1300791 -
RxCUI
1300797 -
RxCUI
1300801 -
RxCUI
1300803 -
RxCUI
2541233 -
RxCUI
2541237
What the source publishes
- Labeler
- Astellas Pharma US, Inc.
- Active ingredients
- mirabegron
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Myrbetriq",
"splId": "fe8998d8-cf08-4e07-b966-33e8de20abf1",
"labels": [
{
"setId": "ba9e9e15-e666-4c56-9271-2e24739cfa2d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba9e9e15-e666-4c56-9271-2e24739cfa2d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ba9e9e15-e666-4c56-9271-2e24739cfa2d"
}
],
"routes": [
"ORAL"
],
"labeler": "Astellas Pharma US, Inc.",
"finished": true,
"packaging": [
{
"sample": true,
"description": "4 CARTON in 1 TRAY (0469-2602-07) / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK",
"package_ndc": "0469-2602-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20120628"
},
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (0469-2602-30) / 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE",
"package_ndc": "0469-2602-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20120628"
},
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (0469-2602-90) / 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE",
"package_ndc": "0469-2602-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20120628"
}
],
"productId": "0469-2602_fe8998d8-cf08-4e07-b966-33e8de20abf1",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
"productNdc": "0469-2602",
"deaSchedule": null,
"genericName": "mirabegron",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MIRABEGRON",
"strength": "50 mg/1"
}
],
"applicationNumber": "NDA202611",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120628",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000185008",
"N0000185007",
"N0000182137",
"N0000190114",
"N0000185503"
],
"unii": [
"MVR3JL3B2V"
],
"rxcui": [
"1300791",
"1300797",
"1300801",
"1300803",
"2541233",
"2541237"
],
"spl_set_id": [
"ba9e9e15-e666-4c56-9271-2e24739cfa2d"
],
"pharm_class_epc": [
"beta3-Adrenergic Agonist [EPC]"
],
"pharm_class_moa": [
"Adrenergic beta3-Agonists [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Cytochrome P450 3A Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]"
],
"manufacturer_name": [
"Astellas Pharma US, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0469-2602_fe8998d8-cf08-4e07-b966-33e8de20abf1"